The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

This section has no associated Explanatory Memorandum

180.  In regulation 221 (amendment of regulation 327 (powers of inspection, sampling and seizure))—U.K.

(a)in paragraph (2), for sub-paragraphs (b) and (c) substitute—

(b)after paragraph (v), insert—

(va)an EU marketing authorisation;.;

(b)for paragraph (3) substitute—

(3) In paragraph (2)(g), after paragraph (iv) insert—

(iva)the requirements of Schedule 12A (further provision as to the performance of pharmacovigilance activities);.;

(c)omit paragraphs (4) and (5).

Commencement Information

I1Sch. 2 para. 180 in force at 31.12.2020 immediately before IP completion day, see reg. 1